Microbix Biosystems Inc T.MBX

New Press Release - Microbix Reports Continued Strong Results for Q3 Fiscal 2024

Revenues of $5.1 million and Net Income of $0.25 million MISSISSAUGA, Ontario, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and first nine months of...read article.

[lscfa]

  Antigen + QAP Qtr ending  4,946,122 Jun 24 5,511,058 Mar 24 4,201,913 Dec 23 4,172,410 Sep 23 4,065,426 Jun 23 4,106

[lscfa]

  Antigen + QAP Qtr ending  Antigen QAP 4,946,122 Jun 24 3,276,469 1,669,653 5,511,058 Mar 24 4,111,462 1,399,596 4,201,913

[prophetoffactz]

I think they said in the conference call that they expect 20-40% growth next fiscal year. Given the margins a few years of growth like that at Kinlytic advances could be golden.

[prophetoffactz]

With sizable interest rate cuts after 40 year high inflation and very sharp interest rate hikes off the zero-bound as well as expected 20-40% growth next year and consistent progress with Kinlytic the next 12 months are poised to be a breakout year.